NDC product
Pyridostigmine Bromide
NDC 42192-626 · Acella Pharmaceuticals, LLC
Key facts
| Product NDC | 42192-626 |
|---|---|
| Proprietary name | Pyridostigmine Bromide |
| Nonproprietary name | pyridostigmine bromide |
| Substances | PYRIDOSTIGMINE BROMIDE |
| Dosage form | SOLUTION |
| Route | ORAL |
| Labeler | Acella Pharmaceuticals, LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA212405 |
| Pharmacologic classes | Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA] |
| Marketing start | Oct 9, 2023 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: